People with HIV show normal antibody longevity after dual COVID-19 vaccination, and strong third dose responses
In a pre-print, not yet peer reviewed, Drs. Zabrina Brumme and Mark Brockman from Simon Fraser University and the BC Centre for Excellence in HIV/AIDS, and members of the Canadian HIV Trials Network, led by Dr. Aslam Anis from the University of British Columbia, demonstrated that responses to COVID-19 vaccines in people living with HIV (PLWH) are similar to those in controls without HIV.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed